← Leaderboards
Marka Van Blitterswijk
Mayo Clinic Jacksonville
$6,748,882
Attributed
$8,701,219
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,701,219 · 7
By mechanism
R01$4,692,923 · 2
RF1$2,351,241 · 1
R21$1,309,774 · 3
U54$347,281 · 1
Top collaborators
- Tania France Gendron5 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Leonard Petrucelli$43,938,031
- Tania France Gendron$4,632,093
- James Shorter$11,511,778
- Wilfried Rossoll$12,130,299
- Yongjie Zhang$2,227,470
Others in their field
Top investigators on “Amyotrophic Lateral Sclerosis”
- Merit E Cudkowicz · Massachusetts General Hospital$54,029,758
- James Dale Berry · Brigham And Women'S Hospital$37,291,450
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Jeffrey D Rothstein · Massachusetts General Hospital$22,909,620
- Teepu Siddique · University Of Chicago$22,641,778
Research focus
Amyotrophic Lateral SclerosisC9orf72Biological MarkersFrontal LobeDiagnosisFrontotemporal DementiaTranscriptGenesMolecularProteinsCohortNeurodegenerative DisordersCerebellumPotential BiomarkerPathologicCollectionBrainSpecimenAutopsyBrain TissueTissuesBloodComplexLength
Grant awards (13)
C9orf72-mediated features transcriptomic signatures and translational studies for frontotemporal dementia and related disorders$788,248
R01 · FY2025 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2025 · NS · contact PI
Uncovering new genes and disease modifiers for ALS and related disorders$347,281
U54 · FY2025 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2024 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2023 · NS · contact PI
C9orf72-mediated features, transcriptomic signatures, and translational studies for frontotemporal dementia and related disorders$2,351,241
RF1 · FY2022 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2022 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2021 · NS · contact PI
Uncovering RNA signatures of C9ORF72-linked ALS and related disorders$430,375
R21 · FY2019 · NS · contact PI
C9ORF72 levels: implications for diagnosis, prognosis, and treatment of ALS and related disorders$195,625
R21 · FY2018 · NS · contact PI
C9ORF72 levels: implications for diagnosis, prognosis, and treatment of ALS and related disorders$234,750
R21 · FY2017 · NS · contact PI
TTR and C9ORF72 in ALS and related disorders$200,361
R21 · FY2017 · NS · contact PI
TTR and C9ORF72 in ALS and related disorders$248,663
R21 · FY2016 · NS · contact PI